Skip to main content

Table 3 Results of subgroup analysis of studies for evaluating DFS

From: Biomarker implication of kallikrein-related peptidases as prognostic tissue substrates of poor survival in colorectal cancer

Subgroup

Number of studies

HR (95% CI)

PHR

Heterogeneity (I2)

Pheterogeneity

Ethnicity

 Caucasian

20

1.28 (1.16–1.43)

< 0.001

46.5%

0.001

 Asian

2

2.28 (1.51–3.46)

< 0.001

0%

0.012

KLK member

 KLK4

1

2.73 (1.04–7.15)

 KLK5

1

1.16 (0.99–1.37)

 KLK6

5

1.63 (1.12–2.39)

0.012

69.4%

0.011

 KLK7

3

1.39 (1.09–1.78)

0.007

0%

0.441

 KLK8

2

1.63 (0.57–4.71)

0.363

88.2%

0.004

 KLK10

4

1.79 (1.00–3.20)

0.05

68.9%

0.022

 KLK11

2

1.55 (0.64–3.76)

0.328

66.5%

0.084

 KLK13

1

1.29 (0.98–1.71)

 KLK14

2

1.43 (1.11–1.84)

0.041

16.1%

0.275

 KLK15

1

1.12 (0.85–1.46)

Detection method

 qRT-PCR

9

2.12 (1.66–2.73)

< 0.001

0%

0.725

 IHC

4

1.89 (1.27–2.81)

0.002

48.9%

0.118

 ELISA

9

1.13 (1.06–2.81)

< 0.001

0%

0.725

  1. qRT-PCR quantitative real-time polymerase chain reaction, IHC immunohistochemistry, ELISA enzyme-linked immunosorbent assay